Technology News and Research

RSS

Improving cancer therapy achieved through taste, odor intervention

Cancer and its therapies, including chemotherapy and radiotherapy, may directly alter and damage taste and odor perception, possibly leading to patient malnutrition, and in severe cases, significant morbidity, according to a Virginia Tech - Wake Forest University Comprehensive Cancer Center compilation of various existing studies.

30 Mar 2009

New cancer genomics web-based tools provide researchers a powerful new to visualize and analyze data

A Cancer Genomics Browser developed by researchers at the University of California, Santa Cruz, provides a new way to visualize and analyze data from studies aimed at improving cancer treatment by unraveling the complex genetic roots of the disease.

30 Mar 2009

Scientists develop molecular system that amplifies certain events

Both cancer cells and the chemicals used to make bombs can foil detection because they appear in trace amounts too small for conventional detection techniques.

30 Mar 2009

Newly created institute 'rare bit of good news' in HIV/AIDS vaccine efforts, editorial says

Although former President George W. Bush "made an ambitious new commitment to the global fight against AIDS," and Congress in 2008 "authorized billions in new spending," lawmakers and philanthropists "will retreat" as the current economic recession continues, a Providence Journal editorial says.

30 Mar 2009

FDA approves IXIARO for Japanese encephalitis

The U.S. Food and Drug Administration has approved IXIARO, a vaccine to prevent Japanese encephalitis (JE) which is caused by a mosquito-transmitted virus found mainly in Asia. IXIARO will be the only vaccine for JE available in the United States.

30 Mar 2009

Gene scan shows body's sleep cycle influences numerous physical functions

The pineal gland - integral to setting the body's sleep and wake cycles - may be involved in a broad range of bodily functions, according to a study by researchers at the National Institutes of Health and other institutions.

30 Mar 2009

Possible new way to stop cancer from spreading

Based on research that reveals new insight into mechanisms that allow invasive tumor cells to move, researchers at the Mayo Clinic campus in Florida have a new understanding about how to stop cancer from spreading.

30 Mar 2009

Angiogenesis inhibitor improves glioblastoma survival by reducing edema

The beneficial effects of anti-angiogenesis drugs in the treatment of the deadly brain tumors called glioblastomas appear to result primarily from reduction of edema - the swelling of brain tissue - and not from any direct anti-tumor effect, according to a study from Massachusetts General Hospital (MGH) researchers.

30 Mar 2009

Senate committee advances budget resolution; debate remains over whether to use reconciliation to fast track health reform

The Senate Budget Committee on Thursday voted 13-10 along party lines to approve a $3.5 trillion fiscal year 2010 budget resolution that does not include budget reconciliation instructions for comprehensive health care reform legislation, CQ Today reports (Clarke et al., CQ Today, 3/26).

30 Mar 2009

Discrimination deterring HIV testing among some high-risk populations in Indonesia, foundation says

Stigma and discrimination aimed at transgendered people and men who have sex with men in Indonesia are significant factors in deterring the groups from receiving HIV tests, the country's Inter Medika Foundation said Tuesday, the Jakarta Globe reports.

30 Mar 2009

New tool in the radiography approach will assist in earlier detection of asbestos-related diseases

Michael Harbut, M.D., MPH, co-director of the National Center for Vermiculite and Asbestos-Related Cancers (NCVAC) at the Barbara Ann Karmanos Cancer Institute in Detroit, MI, and chief of the Center for Occupational and Environmental Medicine Wayne State University, announced the use of a new technology to aid in the diagnosis of asbestos-related lung disease.

30 Mar 2009

Medgenics’ phase I/II clinical trial shows EPODURE continuous anemia treatment lasting 5 months in kidney disease patients

Medgenics has announced that the latest, encouraging results of the Company's ongoing EPODURE Biopump Phase I/II Clinical Trial were presented at the 45th Conference of the Israeli Society of Nephrology and Hypertension, in Israel on March 27, 2009.

29 Mar 2009

Eli Lilly announces inconclusive study results for mGlu2/3 in acute schizophrenia

Eli Lilly and Company has announced inconclusive Phase II clinical trial results from Study HBBI investigating LY2140023 monohydrate, also known as mGlu2/3, for the treatment of patients suffering from acute schizophrenia.

29 Mar 2009

Trial reinforces safety and efficacy of Boston Scientific's two drug-eluting stent platforms

Boston Scientific Corporation has welcomed three-year results from the SPIRIT II Clinical Trial and a pooled meta-analysis of two-year data from the SPIRIT II and III Trials.

29 Mar 2009

ArunA Biomedical to commercialize human embryonic stem cell derived mesenchymal cells

ArunA Biomedical, Inc., has announced that it will make its CELL-EZ brand hMC human mesenchymal progenitor cells commercially available to the research community in mid 2009.

29 Mar 2009

DNA-based assembly line for precision nano-cluster construction

Building on the idea of using DNA to link up nanoparticles - particles measuring mere billionths of a meter - scientists at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory have designed a molecular assembly line for predictable, high-precision nano-construction.

29 Mar 2009

Parahydrogen used to enhance MRI

A new technology which dramatically improves the sensitivity of Magnetic Resonance techniques including those used in hospital scanners and chemistry laboratories has been developed by scientists at the University of York.

29 Mar 2009

New discovery could lead to new methods to block the transmission of HIV

A team of researchers at Mount Sinai School of Medicine and the UC Davis Center for Biophotonics Science and Technology have for the first time captured on video the transfer of human immunodeficiency virus (HIV) from infected to uninfected T cells through structures called virological synapses.

29 Mar 2009

RegeneRx reports phase II venous stasis trial results

Regenerx Biopharmaceuticals Inc. has announced the results of its Phase II clinical trial evaluating the safety and wound-healing efficacy of RGN-137 for the treatment of patients with venous stasis ulcers.

29 Mar 2009

Physio-Control receives FDA 510(k) clearance for LIFEPAK monitor/defibrillator

Physio-Control, Inc., a wholly owned subsidiary of Medtronic, Inc., has announced it has received clearance from the U.S. Food and Drug Administration (FDA) to market the LIFEPAK 15 monitor/defibrillator within the United States.

29 Mar 2009

Technology News and Research

Improving cancer therapy achieved through taste, odor intervention

New cancer genomics web-based tools provide researchers a powerful new to visualize and analyze data

Scientists develop molecular system that amplifies certain events

Newly created institute 'rare bit of good news' in HIV/AIDS vaccine efforts, editorial says

FDA approves IXIARO for Japanese encephalitis

Gene scan shows body's sleep cycle influences numerous physical functions

Possible new way to stop cancer from spreading

Angiogenesis inhibitor improves glioblastoma survival by reducing edema

Senate committee advances budget resolution; debate remains over whether to use reconciliation to fast track health reform

Discrimination deterring HIV testing among some high-risk populations in Indonesia, foundation says

New tool in the radiography approach will assist in earlier detection of asbestos-related diseases

Medgenics’ phase I/II clinical trial shows EPODURE continuous anemia treatment lasting 5 months in kidney disease patients

Eli Lilly announces inconclusive study results for mGlu2/3 in acute schizophrenia

Trial reinforces safety and efficacy of Boston Scientific's two drug-eluting stent platforms

ArunA Biomedical to commercialize human embryonic stem cell derived mesenchymal cells

DNA-based assembly line for precision nano-cluster construction

Parahydrogen used to enhance MRI

New discovery could lead to new methods to block the transmission of HIV

RegeneRx reports phase II venous stasis trial results

Physio-Control receives FDA 510(k) clearance for LIFEPAK monitor/defibrillator

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News